Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

7.790 +0.010 (+0.13%)
Streaming Delayed Price Updated: 1:57 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 482,134
Open 7.730
Bid (Size) 7.770 (4)
Ask (Size) 7.790 (2)
Prev. Close 7.780
Today's Range 7.550 - 7.915
52wk Range 6.320 - 58.23
Shares Outstanding 33,981,877
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-77.5%
-77.5%
1 Month
-40.6%
-40.6%
3 Month
-48.0%
-48.0%
6 Month
-76.3%
-76.3%
1 Year
-83.0%
-83.0%

More News

Read More
Shareholders That Lost Money on RxSight, Inc. (RXST) Should Contact Levi & Korsinsky About Pending Class Action - RXST
Via NewMediaWire
Topics Fraud Lawsuit
Shareholders That Lost Money on RxSight, Inc. (RXST) Should Contact Levi & Korsinsky About Pending Class Action - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST
Via NewMediaWire
Topics Fraud Lawsuit
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST
Via TheNewswire.com
Topics Fraud Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. (RXST) Shareholders
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. (RXST) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
From Pomerantz LLP
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
RXST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)
From Bernstein Liebhard LLP
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc.
From Robbins LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
From Faruqi & Faruqi, LLP
Via Business Wire
Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
From The Rosen Law Firm PA
Via GlobeNewswire
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
From RxSight, Inc.
Via GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
From Glancy Prongay & Murray LLP
Via Business Wire
Berger Montague PC Investigates Potential Securities Law Violations by RxSight, Inc. (NASDAQ: RXST) Following Class Action Filing
From Berger Montague
Via GlobeNewswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire

Frequently Asked Questions

Is RxSight, Inc. - Common Stock publicly traded?
Yes, RxSight, Inc. - Common Stock is publicly traded.
What exchange does RxSight, Inc. - Common Stock trade on?
RxSight, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RxSight, Inc. - Common Stock?
The ticker symbol for RxSight, Inc. - Common Stock is RXST on the Nasdaq Stock Market
What is the current price of RxSight, Inc. - Common Stock?
The current price of RxSight, Inc. - Common Stock is 7.790
When was RxSight, Inc. - Common Stock last traded?
The last trade of RxSight, Inc. - Common Stock was at 08/01/25 01:57 PM ET
What is the market capitalization of RxSight, Inc. - Common Stock?
The market capitalization of RxSight, Inc. - Common Stock is 264.72M
How many shares of RxSight, Inc. - Common Stock are outstanding?
RxSight, Inc. - Common Stock has 265M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.